Browsing Tag
SARS-CoV-2
49 posts
Lilly gets FDA EUA for bebtelovimab in mild-to-moderate Covid-19
Eli Lilly and Company (Lilly) has secured Emergency Use Authorization (EUA) from the US Food and Drug Administration…
February 12, 2022
Glenmark Pharmaceuticals launches Covid-19 treatment FabiSpray in India
Glenmark Pharmaceuticals and Canadian pharma company SaNOtize Research & Development Corp. have launched the latter’s Nitric Oxide Nasal…
February 9, 2022
Celltrion files IND for phase 3 trial of inhaled Covid-19 cocktail therapy
Celltrion Group (Celltrion Healthcare), a South Korean pharma company, has submitted an investigational new drug (IND) application to…
February 7, 2022
Gilead Sciences gets Veklury FDA approval for non-hospitalized Covid-19 patients
Gilead Sciences has secured expedited approval from the US Food and Drug Administration (FDA) for its nucleotide analog…
January 22, 2022
Biocon gets license for Adagio Therapeutics’ ADG20 for Covid-19 treatment
Biocon Limited said that its subsidiary Biocon Biologics has been given an exclusive license from Adagio Therapeutics, a…
July 26, 2021
Bharat Biotech reports positive Covaxin phase 3 results with 77.8% efficacy
Covaxin phase 3 results : Bharat Biotech, an Indian biotech company, said that Covaxin, its whole virion inactivated…
July 4, 2021
Seegene gets $4.8m order for supplying Covid-19 diagnostic kits to Kuwait
Seegene, a South Korean molecular diagnostics company has been given an order worth more than $4.8 million for…
May 18, 2021
DCGI gives emergency use approval for DRDO’s anti-COVID drug 2-DG
The Drugs Controller General of India (DCGI) has given emergency use approval for 2-deoxy-D-glucose (2-DG) of Defence Research…
May 8, 2021
CORAT begins COR-101 clinical trial in hospitalized Covid patients
CORAT Therapeutics said that it has begun a phase 1b/2 clinical trial of its antibody drug candidate COR-101…
April 26, 2021
Sound Pharmaceuticals gets NIH grant for Covid-19 candidate SPI-1005
Sound Pharmaceuticals has secured a grant of $3.1 million for supporting the evaluation of its COVID-19 treatment candidate…
April 6, 2021